InvestorBrandNetwork (IBN) logo

InvestorBrandNetwork (IBN)

The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.

RSS Feed for InvestorBrandNetwork (IBN)

InvestorNewsBreaks – Market Street Capital Inc. Brings Capital Markets Expertise to Healthcare Financing

October 30, 2026 — Market Street was featured in an article that highlights its capital markets and financial advisory services for middle-market healthcare companies navigating reimbursement uncertainty, industry consolidation, heightened compliance scrutiny and increasingly selective investors. With potential Medicare laboratory reimbursement cuts beginning in 2027, lenders and private equity sponsors are placing greater emphasis on revenue diversification, payer relationships, regulatory compliance and sustainable cash flow when evaluating financing and acquisition opportunities.


NetworkNewsBreaks – Wrap Technologies Inc. (NASDAQ: WRAP) Builds Broader Public Safety Platform Around Integrated Solutions

October 30, 2026 — Wrap Technologies (NASDAQ: WRAP) is expanding its public safety technology strategy by connecting remote restraint, scenario-based training, evidence management and emerging threat-detection systems into a more integrated offering. Its portfolio includes the BolaWrap 150 restraint device, WRAP Reality virtual reality training simulator and WrapShield platform, which initially focuses on detecting and responding to unmanned aircraft threats.


InvestorNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Expands NAMs Strategy to Advance BiTAC(R) Therapies

October 30, 2026 — VERAXA Biotech (NASDAQ: VRXA) is expanding its use of human-relevant preclinical testing methods across its antibody-based cancer drug development programs, aiming to improve the clinical relevance of research findings while reducing animal testing. The company is implementing New Approach Methodologies (“NAMs”), including three-dimensional tumor spheroid models and patient-derived tumor models, in support of its BiTAC(R) T-cell engagers, antibody-drug conjugates and bispecific antibody-drug conjugates.


Canada, Turkey Sign Deal on Renewables, Nuclear Energy, LNG

October 30, 2026 — Energy Ministers from Canada and Turkey have signed a deal that enters both countries into a strategic bilateral partnership focused on renewable energy, nuclear energy, and liquefied natural gas (LNG). Canada’s Minister of Energy & Natural Resources Timothy Hodgson met with Turkey’s Minister of Energy & Natural Resources during an Istanbul summit and signed the cooperation statement in the presence of Turkish President Recep Tayyip Erdoğan and Canadian Prime Minister Mark Carney.


Analysis Finds National Energy Storage Targets Fall Short of Global Pledge

October 30, 2026 — According to a recent analysis conducted by Ember, national energy storage targets for 2030 collectively fall 45% short of the 1,500-gigawatt global target agreed at COP29, despite rapid growth in actual installations. It would be insightful to hear how firms like Tesla Inc.


Dual-Impact Antibody Combats Multiple Tumor Types in Preclinical Study

October 30, 2026 — Immunotherapy is a relatively new approach in the treatment of cancer and it has had profound effects on the patients who are responsive to these treatments. Researchers have been working to find ways of making the therapy effective for more categories of patients, since the current immunotherapies don’t work for everyone.


Company Vehicle Regulations Could Create 344,000 Jobs in Europe

October 30, 2026 — A recently-proposed company-vehicle policy has the potential to create hundreds of thousands of new job opportunities across Europe at a time when the continent’s auto sector is facing a historic decline. According to the Fraunhofer ISI Study, company vehicles represent the fastest way for Europe to turn its ongoing transition to battery electric vehicles (BEVs) into an active job creator.


Anthropic Files Paperwork to Go Public

October 30, 2026 — Anthropic has taken a major step toward becoming a publicly traded company, filing paperwork on Monday for an initial public offering that could rank among the biggest market debuts ever. The IPO comes at a time when lots of questions are being asked about the trajectory of the AI industry and the massive debt being used to fund expansion projects.